Advanced search
Publication Cover
Leukemia & Lymphoma Volume 63, 2022 - Issue 14
Submit an article Journal homepage
82
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Non-leukemic presentation of acute promyelocytic leukemia as a testicular mass with associated non-canonical FLT3 mutation

Barina Aqila Department of Pathology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USACorrespondence[email protected]
,
Juehua Gaoa Department of Pathology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA
,
Heidi R. Rahnb Winfield Pathology Consultants, Northwestern Medicine, Winfield, IL, USA
,
Madina Sukhanovaa Department of Pathology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USAORCID Iconhttps://orcid.org/0000-0002-1843-7038
ORCID Icon,
Xinyan Lua Department of Pathology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA
,
Jessica Altmanc Department of Medicine, Hematology Oncology Division, Feinberg School of Medicine, Chicago, IL, USA
,
Lawrence Jenningsa Department of Pathology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA
,
Qing Chena Department of Pathology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA
&
Yi-Hua Chena Department of Pathology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA
 show all
Pages 3493-3496 | Received 27 Jul 2022, Accepted 19 Sep 2022, Published online: 10 Oct 2022

References

  • Avni B, Koren-Michowitz M. Myeloid sarcoma: current approach and therapeutic options. Ther Adv Hematol. 2011;2(5):309–316.
  • Yamauchi K, Yasuda M. Comparison in treatments of nonleukemic granulocytic sarcoma: report of two cases and a review of 72 cases in the literature. Cancer. 2002;94(6):1739–1746.
  • Wang ZY, Chen Z. Acute promyelocytic leukemia: from highly fatal to highly curable. Blood. 2008;111(5):2505–2515.
  • Shimizu H, Saitoh T, Hatsumi N, et al. Clinical significance of granulocytic sarcoma in adult patients with acute myeloid leukemia. Cancer Sci. 2012;103(8):1513–1517.
  • Vega‐Ruiz A, Faderl S, Estrov Z, et al. Incidence of extramedullary disease in patients with acute promyelocytic leukemia: a single‐institution experience. Int J Hematol. 2009;89(4):489–496.
  • Neiman RS, Barcos M, Berard C, et al. Granulocytic sarcoma: a clinicopathologic study of 61 biopsied cases. Cancer. 1981;48(6):1426–1437.
  • Montesinos P, Díaz-Mediavilla J, Debén G, et al. Central nervous system involvement at first relapse in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy without intrathecal prophylaxis. Haematologica. 2009;94(9):1242–1249.
  • McIlwain L, Sokol L, Moscinski LC, et al. Acute myeloid leukemia mimicking primary testicular neoplasm. Presentation of a case with review of literature. Eur J Haematol. 2003;70(4):242–245.
  • Valbuena JR, Admirand JH, Lin P, et al. Myeloid sarcoma involving the testis. Am J Clin Pathol. 2005;124(3):445–452.
  • Tsimberidou AM, Kantarjian HM, Wen S, et al. Myeloid sarcoma is associated with superior event free survival compared with acute myeloid leukemia. Cancer. 2008;113(6):1370–1378.
  • Coombs CC, Tallman MS, Levine RL. Molecular therapy for acute myeloid leukemia. Nat Rev Clin Oncol. 2016;13(5):305–318.
  • Breccia M, Carmosino I, Diverio D, et al. Early detection of meningeal localization in acute promyelocytic leukaemia patients with high presenting leucocyte count. Br J Haematol. 2003;120(2):266–270.
  • Ibáñez M, Carbonell-Caballero J, García-Alonso L, et al. The mutational landscape of acute promyelocytic leukemia reveals an interacting network of co-occurrences and recurrent mutations. PLoS One. 2016;11(2):e0148346.
  • Frohling S, Scholl C, Levine RL, et al. Identification of driver and passenger mutations of FLT3 by high-throughput DNA sequence analysis and functional assessment of candidate alleles. Cancer Cell. 2007;12(6):501–513.
  • Heidel F, Solem FK, Breitenbuecher F, et al. Clinical resistance to the kinase inhibitor PKC412 in acute myeloid leukemia by mutation of Asn-676 in the FLT3 tyrosine kinase domain. Blood. 2006;107(1):293–300.
  • Daver N, Price A, Benton BC, et al. First report of sorafenib in patients with acute myeloid leukemia harboring non-canonical FLT3 mutations. Front Oncol. 2020;10:1538.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.